One study (Mansur et al. 2020) reported that BD patients were taking infliximab (a TNF-α antagonist) to improve depressive symptoms; the remaining studies reported that patients had not taken any immunomodulators or anti-inflammatory drugs in the past 4 weeks. The gene discussed is TNF; the disease is Behcet disease.